American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 952-965 , June 2008

A 1-Year Randomized Trial of Calcium Acetate Versus Sevelamer on Progression of Coronary Artery Calcification in Hemodialysis Patients With Comparable Lipid Control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) Study

  • Wajeh Qunibi, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Texas Health Sciences Center, San Antonio, TX
    • Corresponding Author InformationAddress correspondence to Wajeh Y. Qunibi, MD, Professor of Medicine, Medical Director of Dialysis Services, University of Texas Health Sciences Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229-3900.
  • ,
  • Moustafa Moustafa, MD

      Affiliations

    • South Carolina Nephrology and Hypertension, Orangeburg, SC
  • ,
  • Larry R. Muenz, PhD

      Affiliations

    • Larry R. Muenz & Associates, Gaithersburg, MD
  • ,
  • David Y. He, MS

      Affiliations

    • Larry R. Muenz & Associates, Gaithersburg, MD
  • ,
  • Paul D. Kessler, MD

      Affiliations

    • Nabi Biopharmaceuticals, Rockville, MD
  • ,
  • Jose A. Diaz-Buxo, MD

      Affiliations

    • Fresenius Medical Care, Waltham, MA
  • ,
  • Mathew Budoff, MD

      Affiliations

    • Los Angeles Biomedical Research Institute at Harbor UCLA, Torrance, CA.
  • ,
  • CARE-2 Investigators

Received 30 October 2007 ,Accepted 26 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 A list of the CARE-2 Investigators appears at the end of this article.

 Trial registration: www.clinicaltrials.gov; study number: NCT00211939.

 Originally published online as doi:10.1053/j.ajkd.2008.02.298 on April 17, 2008.

PII: S0272-6386(08)00526-X

doi: 10.1053/j.ajkd.2008.02.298

American Journal of Kidney Diseases
Volume 51, Issue 6 , Pages 952-965 , June 2008